Prasugrel Versus High Dose Clopidogrel in Patients With Stable Coronary Artery Disease and High Platelet Reactivity While on Chronic Clopidogrel Treatment.
Phase of Trial: Phase III
Latest Information Update: 31 Aug 2011
At a glance
- Drugs Prasugrel (Primary) ; Clopidogrel
- Indications Coronary artery disease; Embolism and thrombosis
- Focus Pharmacodynamics
- 31 Aug 2011 Results presented at the ESC Congress 2011: Annual Congress of the European Society of Cardiology.
- 31 Aug 2011 Primary endpoint 'Platelet-aggregation' has been met.
- 21 Apr 2011 Actual end date (April 2011) added as reported by ClinicalTrials.gov.